32.JPG)
Antibody Discovery Market Size is valued at USD 7.35 billion in 2023 and is predicted to reach USD 14.52 billion by the year 2031 at a 9.10% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The proliferation of infectious diseases and the development of effective therapeutic antibodies against them are driving forces behind this industry's expansion.
- Rising customer interest in tailored healthcare is anticipated to sustain the expansion of the antibody discovery industry.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- The market acceptance is expected to be hindered by the high costs related to the antibody development process.
Antibody discovery refers to the process of locating new antibodies. The method aims to identify diagnostic or therapeutic antibodies with target-binding and detection capabilities. The employment of hybridoma technology and phage display is commonplace in antibody development. This approach is essential for developing new medicines, vaccines, diagnostic tools, and other therapeutic applications because it allows researchers to create antibodies that recognize and target specific antigens. Humanized, chimeric, murine, and human antibodies are among the many types produced.
The antibody discovery industry is booming with the concerning increase in the incidence of long-term health problems like cancer, diabetes, heart disease, and autoimmune disorders. Antibody discovery services are in high demand because chronic diseases and the subsequent need for appropriate treatments are becoming more common. Furthermore, rising consumer awareness of personalized treatment is expected to propel the antibody discovery industry. Personalized medicine aims to tailor medical treatment by evaluating preexisting biological data using genetic and biomarker tests. The creation of disease-specific antibodies is a key component of personalized medicine.
However, the market growth is hampered by the high-cost criteria for the safety and health of the antibody discovery market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity acrylic acid because the industry is expected to be constrained by the high expenses linked to the antibody discovery process, which will prevent widespread adoption. The market's growth is expected to be hindered by this factor throughout the predicted period. Antibody development was greatly affected by the COVID-19 pandemic. With increased funding for research, technological advancements, and new methodologies, scientists have made tremendous progress toward identifying efficient and selective antibodies. Antibody discovery is expected to experience a surge in the worldwide market because of the COVID-19 pandemic.
Competitive Landscape
Some of the major key players in the antibody discovery market are:
- Danaher Corporation
- Evotec
- Biocytogen
- Genscript Technology Corporation
- Eurofins Scientific
- Creative Biolabs
- Charles River Laboratories
- Sartorius AG
- Twist Bioscience
- Fairjourney Biologics S.A.
Market Segmentation:
The antibody discovery market is segmented based on methods, antibody type, and end user. Method segment includes phage display, hybridoma, and others. By antibody type, the market is segmented into humanized antibodies, human antibodies, chimeric antibodies, and murine antibodies. By end user, the market is segmented into the pharmaceutical and biotechnology industry, research laboratory, and academic laboratory.
Based On The End User, The Academic Laboratory Antibody Discovery Market Segment Is Accounted As A Major Contributor To The Antibody Discovery Market
The academic laboratory antibody discovery market is expected to hold a major global market share in 2022. Academic institutions provide access to cutting-edge research facilities, a diverse pool of experts, and financial support for research projects. Interdisciplinary research and ground-breaking discoveries are fostered by their collaborative atmosphere. In addition, new treatment approaches may emerge from basic research, target identification, and the development of early-stage antibodies, all of which are largely the purview of academia.
Murine Antibody Segment To Witness Growth At A Rapid Rate
The murine antibody industry makes up the bulk of acrylic acid ester usage. Because of their long history of important use in research and therapeutic development, murine antibodies are a treasure trove of information and resources. Murine antibodies are just as important and useful for early screening and research, especially in countries like the US, Germany, the U.K., China, and India.
In The Region, The North American Antibody Discovery Market Holds A Significant Revenue Share
The North American antibody discovery market is expected to register the highest market share in revenue in the near future. It can be attributed to the growth in cancer rates, the robust antibody discovery business, and the innovative nature of the research and development sector's technological foundation. In addition, Asia Pacific is projected to grow rapidly in the global antibody discovery market because chronic diseases, like cardiovascular disease, are becoming more common. The increasing prevalence of cardiovascular illness has prompted the development of novel antibodies, driving this sector's growth.
Antibody Discovery Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 7.35 Bn |
|
Revenue Forecast In 2031 |
USD 14.52 Bn |
|
Growth Rate CAGR |
CAGR of 9.10 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Methods, Antibody Type, And End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
Danaher Corporation, Evotec, Biocytogen, Genscript Technology Corporation, Eurofins Scientific, Creative Biolabs, Charles River Laboratories, Sartorius AG, Twist Bioscience, and Fairjourney Biologics S.A. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
